NCT01987427 - A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults | Biotech Hunter

Enrollment

344

Participants

Timeline

Start Date

October 30, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

September 3, 2014

Conditions

Chronic Weight Management

Interventions

DRUG

lorcaserin + phentermine placebo

lorcaserin 10 mg BID + phentermine placebo BID

DRUG

lorcaserin + phentermine-HCl + phentermine placebo

lorcaserin 10 mg BID + phentermine-HCl 15 mg QD + phentermine placebo QD

DRUG

lorcaserin + phentermine-HCl

lorcaserin 10 mg BID + phentermine-HCl 15 mg BID

Trial Locations (13)

10065

Weill Cornell College, New York

23294

National Clinical Research - Richmond, Richmond

23502

National Clinical Research - Norfolk, Norfolk

27710

Duke University, Durham

29621

Radiant Research - South Carolina, Anderson

32804

Translational Research Institute for Metabolism and Diabetes, Orlando

35294

University of Alabama at Birmingham, Birmingham

43212

Radiant Research - Columbus, Columbus

70808

Pennington Biomedical Research Center, Baton Rouge

75231

Radiant Research - Dallas, Dallas

85224

Radiant Research - Arizona, Chandler

92037

Scripps Clinical Research Center, La Jolla

Unknown

Boston Medical Center, Boston

All Listed Sponsors

lead

Eisai Inc.

INDUSTRY